MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, IPSC made $109,164K in revenue. -$9,874K in net income. Net profit margin of -9.05%.

Income Overview

Revenue
$109,164K
Net Income
-$9,874K
Net Profit Margin
-9.05%
EPS
-$0.14
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Collaboration revenue
109,164
Research and development
95,667
General and administrative
24,003
Impairment of long-lived assets
6,763
Total operating expenses
126,433
Loss from operations
-17,269
Interest income
7,346
Other income
275
Total other income
7,621
Loss before provision for income taxes
-9,648
(benefit) provision for income taxes
-68
Net loss
-9,580
Unrealized gain (loss) on investments
-294
Comprehensive loss
-9,874
Basic EPS
-0.14
Diluted EPS
-0.14
Basic Average Shares
86,556,515
Diluted Average Shares
86,556,515
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$9,874K Net loss-$9,580K Unrealized gain (loss) oninvestments-$294K (benefit) provision forincome taxes-$68K Interest income$7,346K Other income$275K Loss beforeprovision for income taxes-$9,648K Total other income$7,621K Loss from operations-$17,269K Collaboration revenue$109,164K Total operatingexpenses$126,433K Research and development$95,667K General andadministrative$24,003K Impairment of long-livedassets$6,763K

Century Therapeutics, Inc. (IPSC)

Century Therapeutics, Inc. (IPSC)